These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28622429)

  • 1. Synthesis and Antigenic Evaluation of Oligosaccharide Mimics of Vi Antigen from Salmonella typhi.
    Zhang GL; Yang L; Zhu J; Wei M; Yan W; Xiong DC; Ye XS
    Chemistry; 2017 Aug; 23(44):10670-10677. PubMed ID: 28622429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of di- and tri-saccharide fragments of Salmonella typhi Vi capsular polysaccharide and their zwitterionic analogues.
    Fusari M; Fallarini S; Lombardi G; Lay L
    Bioorg Med Chem; 2015 Dec; 23(23):7439-47. PubMed ID: 26558515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly α-stereoselective synthesis of oligosaccharide fragments of the Vi antigen from Salmonella typhi and their antigenic activities.
    Yang L; Zhu J; Zheng XJ; Tai G; Ye XS
    Chemistry; 2011 Dec; 17(51):14518-26. PubMed ID: 22095754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of O-acetylated Vi polysaccharide of Salmonella enterica subspecies typhi by enzyme immunoassay.
    Rijpkema S; Durrani Z; Lemercinier X; Jones C
    Biologicals; 2004 Mar; 32(1):11-6. PubMed ID: 15026021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-fluorescence based Vi capsular polysaccharide detection for specific recognition of Salmonella enterica serovar Typhi in clinical samples.
    Pandey SK; Vinayaka AC; Rishi DB; Rishi P; Suri CR
    Anal Chim Acta; 2014 Sep; 841():51-7. PubMed ID: 25109861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vi capsular polysaccharide: Synthesis, virulence, and application.
    Hu X; Chen Z; Xiong K; Wang J; Rao X; Cong Y
    Crit Rev Microbiol; 2017 Aug; 43(4):440-452. PubMed ID: 27869515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi.
    Santander J; Roland KL; Curtiss R
    J Infect Dev Ctries; 2008 Dec; 2(6):412-20. PubMed ID: 19745516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of RpoS in fine-tuning the synthesis of Vi capsular polysaccharide in Salmonella enterica serotype Typhi.
    Santander J; Wanda SY; Nickerson CA; Curtiss R
    Infect Immun; 2007 Mar; 75(3):1382-92. PubMed ID: 17178790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi-CRM(197) glycoconjugate vaccine against Salmonella Typhi.
    Rondini S; Micoli F; Lanzilao L; Pisoni I; Di Cioccio V; Saul AJ; Martin LB
    J Infect Dev Ctries; 2012 Nov; 6(11):763-73. PubMed ID: 23277501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Virulence Polysaccharide of
    Parween F; Yadav J; Qadri A
    Front Cell Infect Microbiol; 2019; 9():141. PubMed ID: 31134159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal Regulation of OmpR and Hfq and Their Regulatory Actions on the Vi Polysaccharide Capsular Antigen in Salmonella enterica Serovar Typhi.
    Zhang Y; Xia L; Lin L; Tang H; Osei-Adjei G; Xu S; Zhang Y; Huang X
    Curr Microbiol; 2018 Jun; 75(6):773-778. PubMed ID: 29417203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi.
    Kothari S; Kothari N; Kim JA; Lee E; Yoon YK; An SJ; Jones C; Choe WS; Carbis R
    Vaccine; 2013 Oct; 31(42):4714-9. PubMed ID: 23994374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Vi-negative Salmonella enterica serovar typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan.
    Baker S; Sarwar Y; Aziz H; Haque A; Ali A; Dougan G; Wain J; Haque A
    J Clin Microbiol; 2005 Sep; 43(9):4418-25. PubMed ID: 16145086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
    Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
    Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.
    Acharya IL; Lowe CU; Thapa R; Gurubacharya VL; Shrestha MB; Cadoz M; Schulz D; Armand J; Bryla DA; Trollfors B
    N Engl J Med; 1987 Oct; 317(18):1101-4. PubMed ID: 3657877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH; Hong JJ; Choi ES; Lee JW; Park JH
    J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique lipid anchor attaches Vi antigen capsule to the surface of Salmonella enterica serovar Typhi.
    Liston SD; Ovchinnikova OG; Whitfield C
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6719-24. PubMed ID: 27226298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.